LGALS3 and pulmonary arterial hypertension: The glycopolymers reversed Gal-3-induced changesin rat cardiac fibroblasts and VSMCs in vitro andaccumulated in rat lung and heart tissue, highlighting their potentialuse for pulmonary hypertension therapy.